CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Heilongjiang ZBD Pharmaceutical Co Ltd Company Snapshot
Heilongjiang ZBD Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Heilongjiang ZBD Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Chengdu Kanghong Pharmaceutical Group Co Ltd (2019 sales of 3.26 billion Chinese Renmimbi [US$460.63 million] of which 100% was Pharmaceutical Manufacturing), Guizhou Yibai Pharmaceutical Co., Ltd. (3.36 billion Chinese Renmimbi [US$475.32 million] of which 83% was Medical Industry), and Anhui Fengyuan Pharmaceutical (3.24 billion Chinese Renmimbi [US$457.93 million] of which 51% was Medicine Manufacturing).

Sales Analysis. Heilongjiang ZBD Pharmaceutical Co Ltd reported sales of 3.29 billion Chinese Renmimbi (US$465.52 million) for the year ending December of 2019. This represents an increase of 18.3% versus 2018, when the company's sales were 2.78 billion Chinese Renmimbi. Sales of Other Operations saw an increase that was more than double the company's growth rate: sales were up 144.9% in 2019, from 142.15 million Chinese Renmimbi to 348.09 million Chinese Renmimbi. Heilongjiang ZBD Pharmaceutical Co Ltd also saw significant increases in sales in Pharmaceutical Business (up 75.1% to 903.99 million Chinese Renmimbi) . Not all segments of Heilongjiang ZBD Pharmaceutical Co Ltd experienced an increase in sales in 2019: sales of Pharmaceutical Industry fell 3.9% to 2.04 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Heilongjiang ZBD Pharmaceutical Co Ltd
  Stock Performance Chart for Heilongjiang ZBD Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 12.50
(Figures in Chinese Renmimbi)
1 Week 3.1%   13 Weeks 3.9%  
4 Weeks 4.3%   52 Weeks -4.3%  
 
Heilongjiang ZBD Pharmaceutical Co Ltd Key Data:
  Ticker: 603567 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,291,763,050
(Year Ending Jan 2020).
Employees: 2,704
  Currency: Chinese Renmimbi Market Cap: 10,614,500,000
  Fiscal Yr Ends: December Shares Outstanding: 849,160,000
  Share Type: A Gu Closely Held Shares: 743,523,552
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.